@InProceedings{BOOK1,
	author=	{Frederic H. Martini, Robert B. Tallitsch, Judi L. Nath},
	title=	{{Anatomia umana}},
	booktitle=	{{Anatomia umana }},
	year=	{2019},
}

@InProceedings{BOOK2,
	author=	{Luciano Zocchi},
	title=	{{Principi di fisiologia}},
	booktitle=	{{Principi di fisiologia}},
	year=	{2012},
}

@misc{LINFOMIAIL,
	author = {ASSOCIAZIONE ITALIANA CONTRO LEUCEMIE LINFOMI E MIELOMI (AIL)},
	title = {{PATOLOGIE EMATOLOGICHE: LINFOMI}},
	url = {{https://www.ail.it/patologie-e-terapie/patologie-ematologiche/linfomi}},
}

@misc{img1,
	author = {Pharmacy180},
	title = {{Anatomy and Physiology for Health Professionals: Lymphatic System and Immunity
}},
	url = {{https://www.pharmacy180.com/article/lymphatic-system-and-immunity-3637/}},
}

@misc{img2,
	author = {National Cancer Institute },
	title = {{Lymph System}},
	url = {{https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymph-system}},
}

@misc{LNHAIL,
	author = {ASSOCIAZIONE ITALIANA CONTRO LEUCEMIE LINFOMI E MIELOMI (AIL)},
	title = {{LINFOMA NON HODGKIN}},
	url = {{https://www.ail.it/patologie-e-terapie/patologie-ematologiche/linfomi/576-linfoma-non-hodgkin}},
}

@misc{MSD,
	author = {MANUALE MSD-Versione per professionisti},
	title = {{Cellula di Reed-Sternberg}},
	url = {{https://www.msdmanuals.com/it/professionale/multimedia/image/cellula-di-reed-sternberg#}},
}

@misc{LNHAIMAC,
	author = {Associazione italiana malati di cancro parenti e amici (AIMAC)},
	title = {{I linfomi non Hodgkin}},
	url = {{https://www.aimac.it/libretti-tumore/linfomi-non-hodgkin/qual-e-la-differenza-tra-linfoma-di-hodgkin-e-linfomi-non-hodgkin#:~:text=Un%20linfoma%20non%20Hodgkin%20si,dei%20linfomi%20del%20secondo%20tipo}},
}

@misc{AMERICANCS,
	author = {The American Cancer Society medical and editorial content team},
	title = {{Non-Hodgkin Lymphoma Causes, Risk
Factors, and Prevention}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8718.00.pdf}},
}

@misc{AIOM,
	author = {Associazione Italiana di Oncologia Medica (AIOM)},
	title = {{Linee guida linfomi}},
	url = {{https://www.aiom.it/wp-content/uploads/2018/11/2018_LG_AIOM_Linfomi.pdf}},
}

@misc{AIRTUM,
	author = {Associazione Italiana Registri Tumori (AIRTUM)},
	title = {{Cos'è AIRTUM}},
	url = {{https://www.registri-tumori.it/cms/pagine/cosa-%C3%A9-airtum}},
}

@misc{AIRC,
	author = {Associazione Italiana Ricerca Cancro (AIRC)},
	title = {{Guida ai tumori. Linfoma non-Hodgkin}},
	url = {{https://www.airc.it/cancro/informazioni-tumori/guida-ai-tumori/linfoma-non-hodgkin}},
}

@misc{Americanstatistic,
	author = {American Statistic Center},
	title = {{Non-Hodgkin Lymphoma 2022 Estimates}},
	url = {{https://cancerstatisticscenter.cancer.org/#!/}}
}

@misc{reteveneta,
	author = {Rete Ematologica Veneta},
	title = {{Percorsi Diagnostico Terapeutici Assistenziali (PDTA)
LINFOMI NON HODGKIN}},
	url = {{https://rev.aopd.veneto.it/all/PDTA_Linfomi_Non_Hodgkin.pdf}}
}

@misc{LLS,
	author = {Leukemia and Lymphoma Society},
	title = {{Non-Hodgkin Lymphoma}},
	url = {{https://www.lls.org/sites/default/files/2022-07/PS58_NHL_2022.pdf}}
}

@misc{ISTGENT,
	author = {Gentili Oncology},
	title = {{Linfoma Non Hodgkin}},
	url = {{https://www.istitutogentili.com/it/oncologia/linfomi/linfoma-non-hodgkin/#:~:text=L'Indice%20Prognostico%20Internazionale%20(IPI,svolgere%20le%20attivit%C3%A0%20quotidiane)%20e}}
}

@article{MIPI,
author = {LIM, S.Y. and Horsman, Janet and HANCOCK, B.W.},
year = {2010},
month = {01},
pages = {187-188},
title = {The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?},
volume = {1},
journal = {Oncology letters},
doi = {10.3892/ol_00000034}
}

@misc{AMERICANCANCER,
	author = {American Cancer Society},
	title = {{Non-Hodgkin Lymphoma Early
Detection, Diagnosis, and Staging}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8719.00.pdf}}
}

@misc{ISS,
	author = {Istituto Superiore di Sanità},
	title = {{Linfoma non Hodgkin (LNH)}},
	url = {{https://www.issalute.it/index.php/la-salute-dalla-a-alla-z-menu/l/linfoma-non-hodgkin#diagnosi}}
}

@misc{img4-6-7,
	author = {Associazione Italiana di Oncologia Medica (AIOM)},
	title = {{I NUMERI
DEL CANCRO
IN ITALIA
2021}},
	url = {{https://www.aiom.it/wp-content/uploads/2021/10/2021_NumeriCancro_web.pdf}},
}

@misc{img5,
	author = {Associazione Italiana Registri Tumori},
	title = {{I NUMERI
DEL CANCRO
IN ITALIA
2020}},
	url = {{https://www.registri-tumori.it/cms/sites/default/files/pubblicazioni/new_NDC2020-operatori-web.pdf}},
}

@misc{img15-18,
	author = {Ematologia in Progress},
	title = {{Linfoma non Hodgkin}},
	url = {{https://www.ematologiainprogress.it/linfoma-non-hodgkin/}},
}


@misc{img19,
	author = {Info Medics},
	title = {{Indici prognostici per il Linfoma Follicolare}},
	url = {{https://www.infomedics.it/therapeutic-areas/leucemie-e-linfomi/lnh/linfoma-follicolare/indici-prognostici-linfoma-follicolare.html}},
}

@misc{NIH,
	author = {National Cancer Institute},
	title = {{Radiation Therapy to Treat Cancer}},
	url = {{https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy}}
}

@misc{ACSRADIATION,
	author = {American Cancer Society},
	title = {{Treating Non-Hodgkin Lymphoma}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8720.00.pdf}}
}

@misc{MACMILLAN,
	author = {Macmillan Cancer Support},
	title = {{Radiotherapy}},
	url = {{https://www.macmillan.org.uk/cancer-information-and-support/treatment/types-of-treatment/radiotherapy}}
}

@misc{UKRADIOTP,
	author = {Cancer Research UK},
	title = {{Radiotherapy treatment}},
	url = {{https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/treatment/radiotherapy/treatment}}
}

@misc{IMMUNOTP,
	author = {American Cancer Society},
	title = {{Immunotherapy}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/6678.00.pdf}}
}

@misc{LLSIMMUNO,
	author = {Leukemia and Lymphoma Society},
	title = {{Immunotherapy}},
	url = {{https://www.lls.org/sites/default/files/2021-05/FS9_Immunotherapy_Facts2020FINAL.pdf}}
}

@misc{NIHCART,
	author = {National Cancer Institute},
	title = {{CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers}},
	url = {{https://www.cancer.gov/about-cancer/treatment/research/car-t-cells}}
}


@misc{EMATOCART,
	author = {Ematologia In Progress},
	title = {{Cellule CAR-T}},
	url = {{https://www.ematologiainprogress.it/cellule-car-t/}}
}

@misc{LLSCART,
	author = {Leukemia and Lymphoma Society},
	title = {{Chimeric Antigen Receptor (CAR) T-Cell Therapy}},
	url = {{https://www.lls.org/sites/default/files/2022-07/FS27_CART_rev_7_22.pdf}}
}

@misc{AILCENTRI,
	author = {Associazione Italiana contro Leucemie Linfomi e Mielomi (AIL)},
	title = {{I centri autorizzati alla somministrazione delle terapie CAR-T}},
	url = {{https://www.ail.it/patologie-e-terapie/terapie/car-t/l-accesso-alle-car-t/centri-autorizzati}}
}


@article{Frontiers,
author = {Miao, Lele and Zhang, Zhengchao and Ren, Zhijian and Li, Yumin},
year = {2021},
month = {04},
pages = {},
title = {Reactions Related to CAR-T Cell Therapy},
volume = {12},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2021.663201}
}


@article{Cortico,
author = {Liu, Shuangyou and Deng, Biping and Pan, Jing and Yin, Zhichao and Lin, Yuehui and Ling, Zhuojun and Wu, Tong and Gao, Zhiyong and Song, Yanzhi and Zhao, Yongqiang and Tong, Chunrong},
year = {2019},
month = {11},
pages = {228-228},
title = {Corticosteroids Do Not Influence the Efficacy and Kinetics of CAR-T Cells for B-Cell Acute Lymphoblastic Leukemia},
volume = {134},
journal = {Blood},
doi = {10.1182/blood-2019-123051}
}


@article{ASBMT,
author = {Lee, Daniel and Santomasso, Bianca and Locke, Frederick and Ghobadi, Armin and Turtle, Cameron and Brudno, Jennifer and Maus, Marcela and Park, Jae and Mead, Elena and Pavletic, Steven and Go, William and Eldjerou, Lamis and Gardner, Rebecca and Frey, Noelle and Curran, Kevin and Peggs, Karl and Pasquini, Marcelo and Dipersio, John and Brink, Marcel and Neelapu, Sattva},
year = {2018},
month = {12},
pages = {},
title = {ASBMT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells},
volume = {25},
journal = {Biology of Blood and Marrow Transplantation},
doi = {10.1016/j.bbmt.2018.12.758}
}

@misc{MASSIVEBIO,
	author = {Massive Bio},
	title = {{Immunotherapy for Non-Hodgkin Lymphoma}},
	url = {{https://massivebio.com/immunotherapy-for-lymphoma/}}
}

@misc{LOWGRADE,
	author = {Lymphoma Action},
	title = {{Low-grade non-Hodgkin lymphoma}},
	url = {{https://lymphoma-action.org.uk/sites/default/files/media/documents/2022-02/LA_Low-grade%20non-Hodgkin%20lymphoma%20NOV%2021%20DIGITAL.pdf}}
}

@misc{BORTNURSES,
	author = {Myeloma Special Practice Network(M-SPN)},
	title = {{BORTEZOMIB
BEST PRACTICE
A guide for nurses}},
	url = {{https://myeloma.org.au/wp-content/uploads/2019/10/MSPN_Bortezomib_Best_Practice_Final.pdf}}
}

@article{img28,
author = {Knop, Carol and Milliron, Todd},
year = {2012},
month = {11},
pages = {406-10},
title = {Subcutaneous Administration of Bortezomib: Strategies to Reduce Injection Site Reactions},
volume = {3},
journal = {Journal of the advanced practitioner in oncology},
doi = {10.6004/jadpro.2012.3.6.8}
}

@article{BORTEZOMIB,
  title={Subcutaneous Administration of Bortezomib: Strategies to Reduce Injection Site Reactions},
  author={Sandra E. Kurtin and Carol Knop and Todd Milliron},
  journal={Journal of the advanced practitioner in oncology},
  year={2012},
  volume={3},
  pages={406 - 410}
}

@misc{TRAPIANTO,
	author = {Unità Operativa e Centro Trapianti di Midollo
Osseo “Wilma Deplano”.
Ospedale Oncologico “Armando Businco”
Cagliari},
	title = {{IL TRAPIANTO DI MIDOLLO OSSEO
O DI CELLULE STAMINALI
EMOPOIETICHE PERIFERICHE
Guida informativa per i pazienti}},
	url = {{http://www.aslcagliari.it/documenti/8_26_20081031103940.pdf}}
}

@misc{STEMCELLS,
	author = {American Cancer Society},
	title = {{Stem Cell or Bone Marrow Transplant}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/128.00.pdf}}
}

@misc{LLSBLOOD,
	author = {Leukemia and Lymphoma Society},
	title = {{Blood and Marrow
Stem Cell
Transplantation
Guide}},
	url = {{https://www.lls.org/sites/default/files/2021-05/PS40_BloodMarrow_2018.pdf}}
}

@misc{img35,
	author = {Fondazione Italiana Linfomi (FIL)},
	title = {{Transplantation}},
	url = {{https://filinf.it/en/about-limphomas/transplantation/}},
}


@article{TRANS,
author = {Li, Caixia and Zhang, Ying and Zhang, Changfeng and Chen, Jia and Lou, Xiaoyan and Chen, Xiaochen and Kang, Liqing and Xu, Nan and Li, Minghao and Tan, Jingwen and Sun, Xiuli and Zhou, Jin and Yang, Zhen and Zong, Xiangping and Wang, Pu and Xu, Ting and Qu, Changju and Huang, Haiwen and Jin, Zhengming and Wu, Depei},
year = {2019},
month = {07},
pages = {},
title = {Comparation of CART19 and autologous stem-cell transplantation for refractory/relapsed non-Hodgkin's lymphoma},
volume = {5},
journal = {JCI insight},
doi = {10.1172/jci.insight.130195}
}


@article{GVHD,
author = {Martin, Paul and Rizzo, J. and Wingard, John and Ballen, Karen and Curtin, Peter and Cutler, Corey and Litzow, Mark and Nieto, Yago and Savani, Bipin and Schriber, Jeffrey and Shaughnessy, Paul and Wall, Donna and Carpenter, Paul},
year = {2012},
month = {04},
pages = {1150-63},
title = {First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation},
volume = {18},
journal = {Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
doi = {10.1016/j.bbmt.2012.04.005}
}

@misc{img38,
	author = {National Marrow Donor Program},
	title = {{GVHD signs and symptoms}},
	url = {{https://bethematch.org/patients-and-families/life-after-transplant/physical-health-and-recovery/gvhd-signs-and-symptoms/}},
}

@misc{CHEMOUK,
	author = {Cancer Research UK},
	title = {{Chemotherapy treatment}},
	url = {{https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/treatment/chemotherapy/about}}
}

@misc{CHEMOAMERICAN,
	author = {American Cancer Society},
	title = {{How Is Chemotherapy Used to Treat
Cancer?}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8417.00.pdf}}
}

@misc{LYMPHACTION,
	author = {Lymphoma Action},
	title = {{Chemotherapy}},
	url = {{https://lymphoma-action.org.uk/sites/default/files/media/documents/2021-01/LYMweb0032Chemo2021v7_0.pdf}}
}

@misc{CNS,
	author = {Lymphoma Action},
	title = {{CNS prophylaxis}},
	url = {{https://lymphoma-action.org.uk/sites/default/files/media/documents/2020-12/LYMweb0098CNSProphylaxis2020v3_0.pdf}}
}

@misc{img39,
	author = {CURE SEARCH},
	title = {{Lumbar Puncture (Spinal Tap)}},
	url = {{https://curesearch.org/Lumbar-Puncture}},
}

@misc{HIGHGRADE,
	author = {Lymphoma Action},
	title = {{High-grade
non-Hodgkin
lymphoma}},
	url = {{https://lymphoma-action.org.uk/sites/default/files/media/documents/2022-01/REPRINT%20High-grade%20non-Hodgkin%20lymphoma%20NOV%2021%20DIGITAL.pdf}}
}

@misc{AIOMTOSS,
	author = {Associazione Italiana di Oncologia Medica (AIOM)},
	title = {Linee guida GESTIONE DELLA TOSSICIT\'A EMATOPOIETICA IN ONCOLOGIA}},
	url = {{https://snlg.iss.it/wp-content/uploads/2022/01/LG-458-AIOM_ToxEmatopoietica.pdf}}
}

@misc{LLSLOWCELLS,
	author = {Leukemia and Lymphoma Society},
	title = {SIDE-EFFECT MANAGEMENT: Managing Low Blood Cell Counts}},
	url = {{https://www.lls.org/sites/default/files/2022-07/FF10_SideEffects_BloodCells.pdf}}
}

@misc{AMERICANLOWCELLS,
	author = {American Cancer Society},
	title = {Low Red Blood Cell Counts (Anemia)}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/7529.pdf}}
}

@misc{AMERICANPLATELET,
	author = {American Cancer Society},
	title = {Low Platelet Count (Bleeding)}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8900.00.pdf}}
}

@misc{AMERICANFERTILITY,
	author = {American Cancer Society},
	title = {How Cancer And Cancer Treatment Can
Affect Fertility}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/9255.00.pdf}}
}

@misc{UKFERTILITY,
	author = {Cancer Research UK},
	title = {Sex and fertility}},
	url = {{https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/living-with/sex-fertility}}
}

@misc{ISSESPO,
	author = {ISTITUTO SUPERIORE DI SANITÀ},
	title = {Esposizione professionale
a chemioterapici antiblastici:
rischi per la riproduzione
e strategie per la prevenzione}},
	url = {{https://www.ciip-consulta.it/images/Rischiochimico/Antiblastici%20esposizione_chemioterapici%20%20ISS.pdf}}
}

@misc{FNOPI,
	author = {MINISTERO DELLA SANITÀ DIPARTIMENTO DELLA PREVENZIONE COMMISSIONE ONCOLOGICA NAZIONALE},
	title = {Linee guida per la sicurezza e la salute dei lavoratori esposti a chemioterapici antiblastici in ambiente sanitario}},
	url = {{https://www.fnopi.it/wp-content/uploads/PROV050899.pdf}}
}

@misc{GAVECELTCVC,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {Cateteri	Midline	vs.	altri	accessi	
venosi	periferici	nella	terapia	
endovenosa	}},
	url = {{https://gavecelt.it/nuovo/sites/default/files/uploads/Gli-accessi-venosi-periferici-oggi.pdf}}
}

@misc{GAVECELTracc2021,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {RACCOMANDAZIONI GAVeCeLT 2021
PER LA INDICAZIONE, L’IMPIANTO E LA GESTIONE
DEI DISPOSITIVI PER ACCESSO VENOSO}},
	url = {{https://gavecelt.it/nuovo/sites/default/files/uploads/Raccomandazioni%20GAVeCeLT%202021%20-%20v.2.0.pdf}}
}

@misc{img40,
	author = {Azienda Ospedaliera
Ospedali Riuniti Marche Nord},
	title = {{Posizionamento Picc e Midline}},
	url = {{https://www.ospedalimarchenord.it/percorsi-di-cura/posizionamento-picc-e-midline/}},
}

@misc{img41,
	author = {Blausen.com staff (2014)},
	title = {{"Medical gallery of Blausen Medical 2014"}},
	url = {{https://en.wikipedia.org/wiki/Central_venous_catheter}},
}

@misc{img42,
	author = {National Cancer Institute},
	title = {{Port-a-cath}},
	url = {{https://www.cancer.gov/publications/dictionaries/cancer-terms/def/port-a-cath}},
}

@misc{AIOMCVC,
	author = {Associazione Italiana di Oncologia Medica (AIOM)},
	title = {Working Group Nursing
Gestione infermieristica
degli accessi vascolari centrali a medio e lungo termine
nel paziente oncologico}},
	url = {{https://www.aiom.it/wp-content/uploads/2021/09/2021_Gestione_infermieristica_AV_WGNAIOM.pdf}}
}


@article{img43,
author = {Guiffant, Gerard and Durussel, Jean and Flaud, Patrice and Vigier, Jean and Merckx, Jacques},
year = {2012},
month = {04},
pages = {31-7},
title = {Flushing ports of totally implantable venous access devices, and impact of the Huber point needle bevel orientation: Experimental tests and numerical computation},
volume = {5},
journal = {Medical devices (Auckland, N.Z.)},
doi = {10.2147/MDER.S30029}
}

@misc{img44,
	author = {LIFC Lazio Comitato OFFICIUM},
	title = {{Port-a-cath
Gestione
domiciliare}},
	url = {{https://www.officiumroma.it/wp-content/uploads/2017/09/tre-ante-porth.pdf}},
}

@misc{img45,
	author = {Centro di Riferimento Oncologico di Aviano (CRO)},
	title = {{GESTIONE INFERMIERISTICA DEL
PORT}},
	url = {{https://www.burlo.trieste.it/sites/default/files/slides-corsi/presentazione_su_Port-a-Cath.pdf}},
}

@misc{img46,
	author = {NURSE TIMES},
	title = {{Cateteri Venosi Centrali e sistema needle-free connectors (NFC). Pills}},
	url = {{https://nursetimes.org/cateteri-venosi-centrali-e-sistema-needle-free-connectors-nfc-pills/55254}},
}

@misc{img47,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {{Curos Disinfecting Port Protectors}},
	url = {{http://gavecelt.it/nuovo/sites/default/files/uploads/Uso%20dei%20port%20protectors%20-%20Curos.pdf}},
}

@misc{CRO,
	author = {Centro di Riferimento Oncologico di Aviano (CRO)},
	title = {Il PICC-PORT
Guida per il paziente}},
	url = {{https://www.cro.it/export/sites/cro/it/biblioteca/croinforma/pubblicazioni/PICC-PORTpazienti.pdf}}
}

@misc{GAVECELTPICCPORT,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {Il ruolo futuro dei Picc-Port
in Oncologia}},
	url = {{https://gavecelt.it/nuovo/sites/default/files/uploads/Merlicco%20-%20PICC-port.pdf}}
}

@article{MERLICCO,
author = {Merlicco, Domenico and Lombardi, M. and Fino, M.C.},
year = {2020},
month = {02},
pages = {},
title = {PICC-PORT: Valid indication to placement in patient with results of extensive skin burns of the neck and chest in oncology. The first case in the scientific literature},
volume = {68},
journal = {International Journal of Surgery Case Reports},
doi = {10.1016/j.ijscr.2020.02.028}
}


@misc{img49,
	author = {Xunta de Galicia},
	title = {{Types and characteristics of PICCs}},
	url = {{https://femora.sergas.es/Coidados-das-vias-sondas-e-drenaxes/Tipos-?idioma=es&print=1}},
}


@misc{img51,
	author = {ISTITUTO ORTOPEDICO RIZZOLI
SSD Reparto di
CHEMIOTERAPIA DEI TUMORI DELL’APPARATO LOCOMOTORE},
	title = {{C.V.C. BROVIAC-HICKMAN}},
	url = {{https://www.associazionemariocampanacci.it/wp-content/uploads/2019/01/Opuscolo-BROVIAC-7-2018-1.pdf}},
}

@misc{FNOPIRIVISTA,
	author = {Fabio Mozzarelli, Valentina Ferrari},
	title = {LE FLEBITI CORRELATE AI CVP: UTILIZZO DELLA VISUAL INFUSION PHLEBITIS SCORE PER UN’EFFICACE PREVENZIONE-FNOPI L'INFERMIERE}},
	url = {{https://www.infermiereonline.org/2018/10/12/le-flebiti-correlate-ai-cvp-utilizzo-della-visual-infusion-phlebitis-score-per-unefficace-prevenzione/}}
}


@article{img52,
author = {Gallant, Paulette and Schultz, Alyce},
year = {2006},
month = {11},
pages = {338-45},
title = {Evaluation of a Visual Infusion Phlebitis Scale for Determining Appropriate Discontinuation of Peripheral Intravenous Catheters},
volume = {29},
journal = {Journal of infusion nursing : the official publication of the Infusion Nurses Society},
doi = {10.1097/00129804-200611000-00004}
}

@misc{img53,
	author = {Andrea Zanasi
U.O. Medicina Interna, Ospedale di Sassuolo},
	title = {{La gestione degli accessi vascolari:
Prevenzione, riconoscimento e gestione delle
complicanze precoci e tardive }},
	url = {{https://ospedalesassuolo.it/wp-content/uploads/2012/11/Prevenzione-riconoscimento-e-gestione-delle-complicanze-Zanasi.pdf}},
}

@misc{img54-55,
	author = {NURSE TIMES},
	title = {{Lo stravaso dei farmaci chemioterapici: istruzioni per il trattamento}},
	url = {{https://nursetimes.org/lo-stravaso-dei-farmaci-chemioterapici-istruzioni-trattamento/40722}},
}


@misc{img56-57,
	author = {M.Dolores Palmas, Infermiera S.C. Oncologia Medica DH
P.O. A. Businco},
	title = {{Il trattamento degli stravasi
dei farmaci citotossici}},
	url = {{http://www.aslcagliari.it/documenti/8_136_20100615160800.pdf}},
}


@misc{EMODIAL,
	author = {EMODIAL},
	title = {LA GESTIONE DELLE MARSI
(Medical Adhesive Related Skin Injuries)}},
	url = {{https://www.emodial.it/wp-content/uploads/2020/01/07_dossier-marsi-IT.EN-20171124-AQ100-1.pdf}}
}

@article{img58,
author = {Mcnichol, Laurie and Lund, Carolyn and Rosen, Ted and Gray, Mikel},
year = {2013},
month = {06},
pages = {267-281},
title = {Medical Adhesives and Patient Safety: State of the Science Consensus Statements for the Assessment, Prevention, and Treatment of Adhesive-Related Skin Injuries},
volume = {32},
journal = {Orthopaedic nursing / National Association of Orthopaedic Nurses},
doi = {10.1097/NOR.0b013e3182a39caf}
}


@misc{DIETA,
	author = {Regione Siciliana
AZIENDA OSPEDALIERA di rilievo nazionale e di alta specializzazione
ARNAS – GARIBALDI di Catania
U.O.C. di Ematologia
(Unità Accreditata ISO 9001:2008 per la gestione della terapia antitumorale)},
	title = {La Dieta nel Paziente Ematologico
”Una guida per i malati e per i loro familiari”}},
	url = {{http://www.ao-garibaldi.ct.it/ematologia/per-i-medici/pdf/la-dieta-nel-paziente-ematologico.pdf}}
}

@misc{LLSNUTRITION,
	author = {Leukemia and Lymphoma Society},
	title = {Food and Nutrition Facts}},
	url = {{https://www.lls.org/sites/default/files/2021-05/FS24_Food%20%20Nutrition.pdf}}
}

@misc{LINEEGUIDA,
	author = {Regione Emilia-Romagna. Servizio Sanitario Regionale Emilia-Romagna},
	title = {Linee di indirizzo regionali
sulla buona pratica di cura
degli accessi vascolari}},
	url = {{https://bur.regione.emilia-romagna.it/bur/area-bollettini/bollettini-in-lavorazione/n-36-del-18-02-2021-parte-seconda.2021-02-17.5172676924/linee-di-indirizzo-tecnico-agli-enti-del-servizio-sanitario-regionale-in-materia-di-buona-pratica-degli-accessi-vascolari-provvedimenti-in-ordine-alla-propria-determinazione-n-7166-2020/allegato-det-linee-indirizzo-a.2021-02-17.1613558554}}
}

@misc{STRAVASOTOSCANA,
	author = {SERVIZIO SANITARIO DELLA TOSCANA, AZIENDA USL TOSCANA CENTRO. DIPARTIMENTO ONCOLOGICO},
	title = {Protocollo clinico assistenziale
Prevenzione e trattamento dello
stravaso da farmaci antiblastici }},
	url = {{https://areariservata.uslcentro.toscana.it/index.php/documenti-usl-tc/area-sanitaria/dipartimento-oncologico/1347-pc-donc-01-prevenzione-e-trattamento-dello-stravaso-da-farmaci-antiblastici/file}}
}

@misc{COMUNICAZIONE,
	author = {Dott.ssa Monica Cardellicchio},
	title = {La comunicazione tra infermiere e paziente.}},
	url = {{https://www.assocarenews.it/infermieri/la-comunicazione-tra-infermiere-e-paziente}}
}

@misc{NURSE24,
	author = {Carla Gatto, Nurse24},
	title = {L'occhio dell'Infermiere e la comunicazione con il paziente}},
	url = {{https://www.nurse24.it/infermiere/infermiere-comunicazione-paziente.html}}
}

@misc{ISOLAMENTO,
	author = {SISTEMA SOCIO SANITARIO REGIONE LOMBARDIA},
	title = {Policy aziendale per l’isolamento del paziente in Ospedale }},
	url = {{https://www.anmdo.org/wp-content/uploads/2020/09/Procedura-isolamento-2016.pdf}}
}

@misc{ALOPECIA,
	author = {REDAZIONE NURSE24},
	title = {Alopecia in chemioterapia, la prevenzione è possibile}},
	url = {{https://www.nurse24.it/infermiere/testimonianze-infermieri/alopecia-in-chemioterapia-prevenzione-possibile.html}}
}

@misc{HAIRLOSS,
	author = {American Cancer Society},
	title = {Cooling Caps (Scalp Hypothermia) to
Reduce Hair Loss}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8233.00.pdf}}
}

@misc{HAIRLOSS2,
	author = {American Cancer Society},
	title = {Coping With Hair Loss}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8894.00.pdf}}
}

@misc{effetticollaterali,
	author = {Daniela Berardinelli, Nurse24},
	title = {Chemioterapia ed effetti collaterali}},
	url = {{https://www.nurse24.it/infermiere/farmaci/chemioterapia-effetti-collaterali.html}}
}

@misc{mucositi,
	author = {Giuseppe Caldarelli, Nurse24},
	title = {Mucosite del cavo orale nelle neoplasie, come gestirla?}},
	url = {{https://www.nurse24.it/studenti/mucosite-del-cavo-orale-nelle-neoplasie-come-gestirla.html}}
}

@misc{SCALEmucositi,
	author = {D. Musio, M. Trignani},
	title = {TOSSICIT\'A NEI TRATTAMENTI TESTA-COLLO 
    MUCOSITE ORALE}},
	url = {{https://www.congressiairo.it/2017/roma/09.30_Musio-Trignani.pdf}}
}


@misc{img47BIS,
	author = {Vygon Value Life},
	title = {{Scrub the hub versus disinfecting port protectors; the benefits of change}},
	url = {{https://vygon.co.uk/scrub-the-hub-versus-disinfecting-port-protectors-the-benefits-of-change/}},
}

@article{NURSINGCART,
author = {Ellard, Rose and Kenyon, Michelle and Hutt, Daphna and Aerts, Erik and Ruijter, Maaike and Chabannon, Christian and Mohty, Mohamad and Montoto, Silvia and Wallhult, Elisabeth and Murray, John},
year = {2022},
month = {07},
pages = {},
title = {The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities},
volume = {4},
journal = {Clinical Hematology International},
doi = {10.1007/s44228-022-00004-8}
}

@article{article2,
author = {Dudley, Channing and Baer, Brittney and Simons, Rhea},
year = {2019},
month = {09},
pages = {150930},
title = {Utilization of Chimeric Antigen Receptor T-cell Therapy in Adults},
volume = {35},
journal = {Seminars in Oncology Nursing},
doi = {10.1016/j.soncn.2019.08.009}
}

@article{article3,
author = {Cunningham, Kathleen and DiFilippo, Heather and Henes, Kelli and Irwin, Leah and Napier, Ellen and Weber, Elizabeth},
year = {2021},
month = {07},
pages = {151178},
title = {Tisagenlecleucel Therapy: Nursing Considerations for the Outpatient Setting},
volume = {37},
journal = {Seminars in Oncology Nursing},
doi = {10.1016/j.soncn.2021.151178}
}

@article{article4,
author = {Jackson, Stephanie and Wheatley, Tia},
year = {2021},
month = {03},
pages = {151134},
title = {Chimeric Antigen Receptor T-Cell Emergencies: Inpatient Administration, Assessment, and Management},
volume = {37},
journal = {Seminars in Oncology Nursing},
doi = {10.1016/j.soncn.2021.151134}
}

@misc{ONSCART,
	author = {Oncology Nursing Society (ONS)},
	title = {Chimeric Antigen Receptor T-Cell Therapy: A Timeline of Events and Adverse Events}},
	url = {{https://www.ons.org/clinical-practice-resources/chimeric-antigen-receptor-t-cell-therapy-timeline-events-and-adverse}}
}

@article{PAIN,
author = {Balouchi, Abbas and Abdollahimohammad, Abdolghani and Bouya, Salehoddin and Alkhasawneh, Esra},
year = {2018},
month = {10},
pages = {},
title = {Cancer Pain Management Among Oncology Nurses: Knowledge, Attitude, Related Factors, and Clinical Recommendations: a Systematic Review},
journal = {Journal of Cancer Education},
doi = {10.1007/s13187-018-1433-6}
}

@article{PAINONS,
author = {Brant, Jeannine and Eaton, Linda and Irwin, Margaret},
year = {2017},
month = {06},
pages = {4-7},
title = {Cancer-Related Pain: Assessment and Management With Putting Evidence Into Practice Interventions},
volume = {21},
journal = {Clinical Journal of Oncology Nursing},
doi = {10.1188/17.CJON.S3.4-7}
}

@article{CANCERPAINONS,
author = {Gallagher, Eva and Rogers, Barbara and Brant, Jeannine},
year = {2017},
month = {06},
pages = {8-12},
title = {Cancer-Related Pain Assessment: Monitoring the Effectiveness of Interventions},
volume = {21},
journal = {Clinical Journal of Oncology Nursing},
doi = {10.1188/17.CJON.S3.8-12}
}

@article{analgesici,
author = {Rosa, William and Chittams, Jesse and Riegel, Barbara and Ulrich, Connie and Meghani, Salimah},
year = {2019},
month = {10},
pages = {},
title = {Patient Trade-Offs Related to Analgesic Use for Cancer Pain: A MaxDiff Analysis Study},
volume = {21},
journal = {Pain Management Nursing},
doi = {10.1016/j.pmn.2019.07.013}
}

@article{painNOC,
author = {Mello, Bruna and Almeida, Miriam and Pruinelli, Lisiane and Lucena, Amalia},
year = {2019},
month = {02},
pages = {64-72},
title = {Nursing outcomes for pain assessment of patients undergoing palliative care},
volume = {72},
journal = {Revista Brasileira de Enfermagem},
doi = {10.1590/0034-7167-2018-0307}
}

@article{tpnonfarmacologiche,
author = {Lopes-Júnior, Luís and Rosa, Gabriela and Pessanha, Raphael and Schuab, Sara and Nunes, Karolini and Amorim, Maria},
year = {2020},
month = {09},
pages = {},
title = {Efficacy of the complementary therapies in the management of cancer pain in palliative care: A systematic review},
volume = {28},
journal = {Revista Latino-Americana de Enfermagem},
doi = {10.1590/1518-8345.4213.3377}
}
